Universal Viewer †With this week’s introduction of Universal Viewer, GE Healthcare aims to put clinical insight within reach to help radiologists and referring physicians deliver patient results efficiently. Universal Viewer brings together advanced visualization, intelligent productivity tools, and multimodality workflow for oncology and breast imaging all within one intuitive workspace that can be accessed anywhere, anytime. It works with Centricity* PACS, Centricity PACS-IW, and Centricity Clinical Archive. Centricity PACS and Centricity PACS-IW users will find a new dimension of clinical intelligence as they explore Universal Viewer. It is enables seamless workflow with pre- and post-processing. Advanced clinical applications, powered by AW, are embedded to enable oncology quantification, auto bone removal, vessel analysis, and registration. In an industry “first,” Universal Viewer also includes integrated mammography tools for screening and diagnostics, with the ability to display images across a breadth of modalities, support CAD markers and IHE profiles, and connect with reporting systems. Breast Ultrasound Women with dense breast tissue – estimated at 40-45 percent of women in the United States – are more likely to get breast cancer than women without dense breast tissue. GE Healthcare now has the opportunity to integrate 3D automated whole breast ultrasound screening in clinical practice as an adjunct to mammography – a powerful additional tool which can help physicians find previously undetectable cancers. “In women with dense breasts, we can’t see over one-third of breast cancers so we need other technologies, other approaches so the potential of 3D ultrasound in a screening environment is to find these additional cancers that would not have been found with what is now the standard of care,” said Dr. Rachel Brem, Director of Breast Imaging at The George Washington University Hospital in Washington, DC. InSightec Receives FDA Approval for Bone Pain Ultrasound Therapy InSightec’s ExAblate system is exclusively compatible with GE Healthcare’s normal and wide bore systems, including Signa HDxt 1.5T, Signa HDxt 3.0T, Optima MR450 & 450w, and Discovery MR750 & 750w. It combines therapeutic acoustic ultrasound waves with continuous guidance and treatment monitoring by MRI. This unique combination of technologies is called Magnetic Resonance guided Focused Ultrasound Therapy (MRgFUS). Physicians use the MRI to plan and guide the therapy and monitor treatment outcome. The focused ultrasound acoustic energy destroys the nerves causing the pain from bone metastases, resulting in rapid reduction in pain.
“The FDA approval of ExAblate is an exciting next step in GE’s investment in InSightec,” Tom Gentile, president and CEO of GE Healthcare Systems and InSightec board member. “Pain is the most common and most severe symptom for patient’s suffering from bone cancer; we believe that ExAblate can help significantly improve the quality of life for patients. This is the first approved oncology application of ExAblate and we are excited that InSightec will continue researching in this area to expand the applications of this product.”* Trademark of General Electric Company. † 510(k) pending at U.S. FDA and not available for sale in the U.S. GE Healthcare at RSNA 2012 Each year in Chicago, the conference of the Radiological Association of North America (RSNA) provides a forum for showcasing the latest innovations in medical imaging. If you are attending the conference, please visit GE Healthcare at booth number 5433 in McCormick Place south hall. Throughout the week of the event, GE Healthcare will distribute news and information using these digital platforms:
- Digital press kit: newsroom.gehealthcare.com/press-kits/ge-healthcare-at-rsna-2012
- Twitter: @GEHealthcare and hashtag #GEWorks
- YouTube channel: www.youtube.com/gehealthcare
- Flickr: www.flickr.com/people/gehealthcare
- Instagram: instagram.com/generalelectric
Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on increasing access and improving quality and affordability around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com. For our latest news, please visit http://newsroom.gehealthcare.com.